Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESIGN: Dietary Sodium Intake Effects on Ertugliflozin in Type 2 Diabetes
NCT05727579Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), sponsored by Amsterdam University Medical Center. Started Jul 2023; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05727579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05727579.